---
title: disease classification and manifestations of chronic myelogenous leukemia (CML)
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[chronic myelogenous leukemia (CML)]]

# disease classification and manifestations of chronic myelogenous leukemia (CML)Â 

(WHO;Â NCCNÂ v 2.2022)



## Chronic phase (CP) ðŸŒ»
* <15% blasts (peripheral or bone marrow).
* Risk stratification based on
	* [[Sokal score]]Â (BloodÂ 1984;63:789)Â 
	* Euro scoresÂ (J Clin PatholÂ 2001;54:491)
* (3â€“5y pre-TKI)
* 85% of pts, asx, no criteria for accelerated or blast crisis

## Accelerated phase (AP) ðŸ©°
* >15% blasts, or 10-19% blasts in PB or bone marrow 
* â‰¥20% **basos**, of total in blood or bone marrow
* (12â€“18 mos pre-TKI)
* plts <100k,
* clonal evolution (karyotype changes) not seen at dx
* progressive splenomegaly

## Blastic phase (BP) ðŸ¤¯
* â‰¥20% blasts (peripheral or marrow)
* and/or extramedullary leukemia

---

* Most asx or may have mild constitutional s/s related to splenomegaly.

## disease progression
* worsening constitutional sx
* bone pain
* â†‘ spleen size

